Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19-associated coagulopathy (CAC). Data concerning CAC in pregnancy are limited.
Editor - Immune thrombocytopenia (ITP) is a disorder driven by autoimmune-mediated platelet destruction and defined by platelet counts below 100 x 109 L−1, following exclusion of competing aetiologies of thrombocytopenia. It affects about 1–2 per 1,000 pregnancies. Peripartum, the presence of ITP often proves challenging, particularly as it relates to obstetric neuraxial analgesia.
Letters Ann Kinga Malinowski, John Snelgrove and Nan Okun CMAJ June 08, 2020 192 (23) E634; DOI: https://doi.org/10.1503/cmaj.75807 We agree with Cheng and colleagues regarding the need to generate robust evidence through randomized trials.1 However, we note that inclusion of pregnant individuals is conspicuously absent from this call to action. Of investigations related to coronavirus disease 2019 (COVID-19) registered on clinicaltrials.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.